Semaglutide mkt settles into steady growth six months after patent expiry | Industry News
Six months after semaglutide lost patent protection in India, generic brands account for about 74 per cent of…
Generic Ozempic, Mounjaro and GLP-1 market in India: why tirzepatide still leads
When cheaper generic versions of semaglutide – originally developed by Danish drugmaker Novo Nordisk and runaway success under…
DCGI cracks down on indirect promotion of weight-loss prescription drugs
New Delhi: The Drugs Controller General of India (DCGI) has directed all pharmaceutical manufacturers and importers to immediately…
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
India’s anti-obesity drug market is on the brink of a major transformation, with prices of popular weight-loss medications…
8 wellness trends that dominated conversations in 2025
2025 emerged as the year where it became clear that wellness was no longer a passing fad of…